Crispr-cas9 is an adaptive immune defense developed by bacteria and archaea over a long period of evolution against invading viruses and foreign DNA. Crispr-cas9, which makes specific DNA modifications to targeted genes, is at the forefront of gene editing. Crispr-cas9-based gene editing has shown great promise in a range of gene therapy applications, such as blood diseases, tumors and other genetic disorders.
